|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park JC, Citrin DE, Agarwal PK and Apolo
AB: Multimodal management of muscle-invasive bladder cancer. Curr
Probl Cancer. 38:80–108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Rhijn BW, Burger M, Lotan Y, Solsona
E, Stief CG, Sylvester RJ, Witjes JA and Zlotta AR: Recurrence and
progression of disease in non-muscle-invasive bladder cancer: From
epidemiology to treatment strategy. Eur Urol. 56:430–442. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jocham D, Stepp H and Waidelich R:
Photodynamic diagnosis in urology: State-of-the-art. Eur Urol.
53:1138–1148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang LP: Hexaminolevulinate blue light
cystoscopy: A review of its use in the diagnosis of bladder cancer.
Mol Diagn Ther. 18:105–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cordeiro ER, Anastasiadis A, Bus MT,
Alivizatos G, de la Rosette JJ and de Reijke TM: Is photodynamic
diagnosis ready for introduction in urological clinical practice?
Expert Rev Anticancer Ther. 13:669–680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burger M, Grossman HB, Droller M,
Schmidbauer J, Hermann G, Drăgoescu O, Ray E, Fradet Y, Karl A,
Burgués JP, et al: Photodynamic diagnosis of non-muscle-invasive
bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis
of detection and recurrence based on raw data. Eur Urol.
64:846–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Babjuk M, Böhle A, Burger M, Capoun O,
Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, et al: EAU
Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the
Bladder: Update 2016. Eur Urol. Jun 17–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
9
|
Roelants M, Huygens A, Crnolatac I, Van
Cleynenbreugel B, Lerut E, Van Poppel H and de Witte PA: Evans blue
as a selective dye marker for white-light diagnosis of
non-muscle-invasive bladder cancer: An in vitro study. BJU Int.
109:300–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elsen S, Lerut E, Van Cleynenbreugel B,
Van der Aa F, Van Poppel H and de Witte PA: Biodistribution of
Evans blue in an orthotopic AY-27 rat bladder urothelial cell
carincinoma model: Implication for the improved diagnosis of
non-muscle-invasive bladder cancer (NMIBC) using dye-guided
white-light cystoscopy. BJU Int. 116:468–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gardner MJ: Micromethod for the analysis
of evans blue in plasma using ion-pair high-performance liquid
chromatography. J Chromatogr. 381:295–303. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liao Y, Smyth GK and Shi W: FeatureCounts:
An efficient general purpose program for assigning sequence reads
to genomic features. Bioinformatics. 30:923–930. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Risso D, Schwartz K, Sherlock G and Dudoit
S: GC-content normalization for RNA-seq data. BMC Bioinformatics.
12:4802011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Robinson MD and Smyth GK: Moderated
statistical tests for assessing differences in tag abundance.
Bioinformatics. 23:2881–2887. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Statist Soc B. 57:289–300. 1995.
|
|
16
|
Gibson JG and Evans WA: Clinical studies
of the blood volume. I. Clinical application of a method employing
the azo dye ‘Evans blue’ and the spectrophotometer. J Clin Invest.
16:301–316. 1937. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Crooke AC and Morris CJ: The determination
of plasma volume by the Evans blue method. J Physiol. 101:217–223.
1942. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brown MA, Mitar DA and Whitworth JA:
Measurement of plasma volume in pregnancy. Clin Sci (Lond).
83:29–34. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Farquhar WB, Hunt BE, Taylor JA, Darling
SE and Freeman R: Blood volume and its relation to peak O(2)
consumption and physical activity in patients with chronic fatigue.
Am J Physiol Heart Circ Physiol. 282:H66–H71. 2002.PubMed/NCBI
|
|
20
|
Boron WF and Boulpaep EL: Arteries and
veinsMedical physiology. Elsevier Inc.; Philadelphia, PA: pp.
447–462. 2005
|
|
21
|
Gibson JG and Gregersen MI: Toxicity of
two vital dyes used in plasma volume determinations. Am J Physiol
(Proc). 113:501935.
|
|
22
|
Belafsy PC, Blumenfeld L, LePage A and
Nahrstedt K: The accuracy of the modified Evan's blue dye test in
predicting aspiration. Laryngoscope. 113:1969–1972. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanai M, Sakurai T, Yoshinaga K, Aoyagi K,
Hitsumoto T, Yoshinuma M, Uchi T, Noike H, Ohsawa H, Kawamura K, et
al: Percutaneous dye image cardioscopy for detection of endocardial
lesions. Diagn Ther Endosc. 7:29–33. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hewitt KJ, Agarwal R and Morin PJ: The
claudin gene family: Expression in normal and neoplastic tissues.
BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bryan RT and Tselepis C: Cadherin
switching and bladder cancer. J Urol. 184:423–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bryan RT, Atherfold PA, Yeo Y, Jones LI,
Harrison FR, Wallace DM and Jankowski JA: Cadherin switching
dictates the biology of transitional cell carcinoma of the bladder:
Ex vivo and in vitro studies. J Pathol. 215:184–194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
